Cnb Bank Gilead Sciences, Inc. Transaction History

Cnb Bank

$215 Million
Q3 2024

A detailed history of Cnb Bank transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Cnb Bank holds 582 shares of GILD stock, worth $54,678. This represents 0.02% of its overall portfolio holdings.

Number of Shares

582

Previous 579 0.52%

Holding current value

$54,678

Previous $39,000 23.08%

% of portfolio

0.02%

Previous 0.02%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	BUY	$66.59 - $83.99 $199 - $251	3 Added 0.52%	582 $48,000
Q3 2023 Nov 02, 2023	BUY	$73.94 - $80.67 $42,811 - $46,707	579 New	579 $43,000
Q2 2022 Aug 10, 2022	SELL	$57.72 - $65.01 $1,038 - $1,170	-18 Reduced 6.72%	250 $15,000
Q1 2022 Apr 13, 2022	SELL	$57.92 - $72.58 $1,042 - $1,306	-18 Reduced 6.29%	268 $16,000
Q3 2021 Nov 02, 2021	SELL	$67.69 - $73.03 $3,993 - $4,308	-59 Reduced 17.1%	286 $20,000
Q2 2021 Jul 29, 2021	BUY	$63.47 - $69.35 $1,713 - $1,872	27 Added 8.49%	345 $24,000
Q4 2020 Jan 27, 2021	BUY	$56.65 - $64.55 $2,039 - $2,323	36 Added 12.77%	318 $19,000
Q1 2020 May 13, 2020	BUY	$62.63 - $80.22 $15,657 - $20,055	250 Added 781.25%	282 $21,000
Q3 2019 Nov 04, 2019	SELL	$62.51 - $69.0 $6,751 - $7,452	-108 Reduced 77.14%	32 $2,000
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $6,681 - $7,493	108 Added 337.5%	140 $9,000
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $2,076 - $2,421	32 New	32 $2,000

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $118B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cnb Bank, based on Form 13F filings with the SEC.

News

Stay updated on Cnb Bank with notifications on news.

Account